Skip to main content
. 2017 Jun 8;65(7):1057–1061. doi: 10.1136/jim-2017-000445

Figure 1.

Figure 1

Change in SBP (A) and DBP (B) before and after administration of an SGLT2 inhibitor. Square points are shown as mean. SGLT2 inhibitors tended to decrease SBP and DBP, so these changes are statistically significant (p<0.05) before versus after treatment with an SGLT2 inhibitor. DBP, diastolic blood pressure; SBP, systolic blood pressure; SGLT2, sodium-glucose co-transporter 2.